MaveriX Oncology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6.5M

  • Investors
  • 2

MaveriX Oncology General Information

Description

Developer of novel immunotherapies designed to bridge the therapeutic gap in cancer treatment The company's immunotherapies leverage unexploited insights into cancer and immune cell metabolism within the tumor microenvironment which are common to all cancers, enabling medical practitioners to deliver the tumor cell-killing benefits of chemotherapy while generating a strong immune response to attack a wide range of cancers.

Contact Information

Website
www.maverixoncology.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 435 Middlefield Road
  • Palo Alto, CA 94025
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 435 Middlefield Road
  • Palo Alto, CA 94025
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MaveriX Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Oct-2019 $6.5M Completed Pre-Clinical Trials
1. Angel (individual) 02-Jun-2016 Completed Startup
To view MaveriX Oncology’s complete valuation and funding history, request access »

MaveriX Oncology Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view MaveriX Oncology’s complete cap table history, request access »

MaveriX Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel immunotherapies designed to bridge the therapeutic gap in cancer treatment The company's immunotherap
Drug Discovery
Palo Alto, CA
3 As of 2026

Lexington, MA
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MaveriX Oncology Competitors (89)

One of MaveriX Oncology’s 89 competitors is Accent Therapeutics, a Venture Capital-Backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Accent Therapeutics Venture Capital-Backed Lexington, MA
CytoAgents Venture Capital-Backed Pittsburgh, PA
Actym Therapeutics Venture Capital-Backed Berkeley, CA
Artios Venture Capital-Backed Cambridge, United Kingdom
Meditope Biosciences Formerly VC-backed Pasadena, CA
You’re viewing 5 of 89 competitors. Get the full list »

MaveriX Oncology Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

MaveriX Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026102855-A Gemcitabine monophosphate small molecule drug conjugate Pending 02-Feb-2018
JP-2024073414-A Novel small molecule drug conjugate of gemcitabine derivative Pending 02-Feb-2018
AU-2019216514-A1 Novel small molecule drug conjugates of gemcitabine derivatives Inactive 02-Feb-2018
CA-3090272-A1 Novel small molecule drug conjugates of gemcitabine derivatives Pending 02-Feb-2018
EP-3746133-A1 Novel small molecule drug conjugates of gemcitabine derivatives Inactive 02-Feb-2018 C07H19/10
To view MaveriX Oncology’s complete patent history, request access »

MaveriX Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MaveriX Oncology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
PPF Group PE/Buyout Minority
SCTbio PE-Backed Company Minority
To view MaveriX Oncology’s complete investors history, request access »

Ready to get started?

Request a free trial

MaveriX Oncology FAQs

  • When was MaveriX Oncology founded?

    MaveriX Oncology was founded in 2015.

  • Where is MaveriX Oncology headquartered?

    MaveriX Oncology is headquartered in Palo Alto, CA.

  • What is the size of MaveriX Oncology?

    MaveriX Oncology has 3 total employees.

  • What industry is MaveriX Oncology in?

    MaveriX Oncology’s primary industry is Drug Discovery.

  • Is MaveriX Oncology a private or public company?

    MaveriX Oncology is a Private company.

  • What is the current valuation of MaveriX Oncology?

    The current valuation of MaveriX Oncology is .

  • What is MaveriX Oncology’s current revenue?

    The current revenue for MaveriX Oncology is .

  • How much funding has MaveriX Oncology raised over time?

    MaveriX Oncology has raised $7.5M.

  • Who are MaveriX Oncology’s investors?

    PPF Group and SCTbio have invested in MaveriX Oncology.

  • Who are MaveriX Oncology’s competitors?

    Accent Therapeutics, CytoAgents, Actym Therapeutics, Artios, and Meditope Biosciences are some of the 89 competitors of MaveriX Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process